Kent Riemondy
- Molecular Biology top 10%
- Hematology top 2%
- Cancer Research top 10%
- Pulmonary and Respiratory Medicine top 10%
- Immunology
- Co-authors
- Jay R. HesselberthAustin E. GillenJonathan A. GutmanDiana AbbottClayton A. SmithAngelo D’AlessandroCourtney L. JonesEnkhtsetseg Purev
- Topics
- Single-cell and spatial transcriptomics (8 papers)RNA Research and Splicing (8 papers)Glioma Diagnosis and Treatment (5 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Kent Riemondy
37 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 84
- Molecular Biology 826
- Hematology 363
- Cancer Research 225
- Pulmonary and Respiratory Medicine 211
- Immunology 205
Countries citing papers authored by Kent Riemondy
This map shows the geographic impact of Kent Riemondy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kent Riemondy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kent Riemondy more than expected).
Fields of papers citing papers by Kent Riemondy
This network shows the impact of papers produced by Kent Riemondy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kent Riemondy. The network helps show where Kent Riemondy may publish in the future.
Co-authorship network of co-authors of Kent Riemondy
This figure shows the co-authorship network connecting the top 25 collaborators of Kent Riemondy. A scholar is included among the top collaborators of Kent Riemondy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kent Riemondy. Kent Riemondy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 4 | |
| 3 | 4 | |
| 4 | 70 | |
| 5 | 1 | |
| 6 | 6 | |
| 7 | 11 | |
| 8 | 4 | |
| 9 | 5 | |
| 10 | 14 | |
| 11 | 43 | |
| 12 | 4 | |
| 13 | 99 | |
| 14 | 52 | |
| 15 | 14 | |
| 16 | Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemiabreakdown → | 481 |
| 17 | 27 | |
| 18 | 77 | |
| 19 | 16 | |
| 20 | 74 |
About Kent Riemondy
Kent Riemondy is a scholar working on Genetics, Molecular Biology and Cancer Research, having authored 38 papers that have together received 1.4k indexed citations. Recurring topics across this work include Single-cell and spatial transcriptomics (8 papers), RNA Research and Splicing (8 papers) and Glioma Diagnosis and Treatment (5 papers). The work is most often cited by research in Hematology (363 citations), Cancer Research (225 citations) and Molecular Biology (826 citations). Kent Riemondy has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Jay R. Hesselberth, Austin E. Gillen, Jonathan A. Gutman, Diana Abbott, Clayton A. Smith, Angelo D’Alessandro, Courtney L. Jones, Enkhtsetseg Purev, Brett M. Stevens and Amanda Winters. Their work appears in journals such as Nucleic Acids Research, Journal of Clinical Investigation and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.